{"result": "(\"entity\"<|>Hiperquilomicronemia<|>EVENT<|>Hiperquilomicronemia is a medical condition characterized by elevated levels of triglycerides in the blood, often leading to pancreatitis and other complications.)\n##\n(\"entity\"<|>Hiperlipidemia Familiar Combinada<|>EVENT<|>Hiperlipidemia Familiar Combinada is a genetic disorder that results in high levels of lipids in the blood, increasing the risk of cardiovascular diseases.)\n##\n(\"entity\"<|>Disbetalipoproteinemia<|>EVENT<|>Disbetalipoproteinemia is a disorder that affects lipid metabolism, leading to abnormal levels of lipoproteins in the blood.)\n##\n(\"entity\"<|>Hipertrigliceridemia Familiar<|>EVENT<|>Hipertrigliceridemia Familiar is a genetic condition characterized by high triglyceride levels, which can lead to pancreatitis and other health issues.)\n##\n(\"entity\"<|>Xantomas Eruptivos<|>EVENT<|>Xantomas Eruptivos are small, eruptive skin lesions that occur due to high levels of triglycerides in the blood, often associated with conditions like hipertrigliceridemia.)\n##\n(\"entity\"<|>Lipidemia Retinalis<|>EVENT<|>Lipidemia Retinalis is a condition where the retinal blood vessels appear white due to the presence of lipids, often seen in patients with severe hyperlipidemia.)\n##\n(\"relationship\"<|>Hiperquilomicronemia<|>Hiperlipidemia Familiar Combinada<|>Hiperquilomicronemia and Hiperlipidemia Familiar Combinada are both conditions related to lipid metabolism disorders<|>4)\n##\n(\"relationship\"<|>Hiperquilomicronemia<|>Disbetalipoproteinemia<|>Hiperquilomicronemia and Disbetalipoproteinemia are both associated with abnormal lipid levels in the blood<|>4)\n##\n(\"relationship\"<|>Hiperlipidemia Familiar Combinada<|>Disbetalipoproteinemia<|>Hiperlipidemia Familiar Combinada and Disbetalipoproteinemia are both genetic disorders affecting lipid metabolism<|>4)\n##\n(\"relationship\"<|>Hipertrigliceridemia Familiar<|>Hiperquilomicronemia<|>Hipertrigliceridemia Familiar can lead to conditions like Hiperquilomicronemia due to high triglyceride levels<|>5)\n##\n(\"relationship\"<|>Xantomas Eruptivos<|>Hipertrigliceridemia Familiar<|>Xantomas Eruptivos are a common skin manifestation of Hipertrigliceridemia Familiar<|>6)\n##\n(\"relationship\"<|>Lipidemia Retinalis<|>Hiperquilomicronemia<|>Lipidemia Retinalis is a clinical manifestation often seen in patients with Hiperquilomicronemia<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Familia. SEMERGEN. 2014;40(7):374-380.                                                                                    cesivo raro que altera el catabolismo de las VLDL e IDL. Además, los individuos con este\n                                                                                                                                                          trastorno presentan HDL-2 elevada, ya que la lipasa hepática interviene en la conversión de\n     8.4 Casos clínicos. Caso clínico 1                                                                                                                   HDL-2 a HDL-3.\n                                                                                                                                                          Déficit de apo-V. Es una apolipoproteína de reciente descubrimiento; circula en menor con-\n                                                                                                                                                          centración que las demás. No se conoce bien el mecanismo de acción, pero parece que\n       42     ¿Cuál es el diagnóstico más probable?                                                                                                       tiene un papel clave en la unión de las VLDL y los quilomicrones con LPL. La mutación en\n                                                                                                                                                          ambos alelos de la apo-V puede ocasionar quilomicronemia en algunos individuos.\n              A. Hiperquilomicronemia primaria. Fenotipo I de Friedriksön.\n              B. Hiperlipidemia familiar combinada. Fenotipo IIb de Friedriksön.                                                                          Referencias:\n                                                                                                                                                          • Cardona F, Alcaide J, Fernández García JC. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española\n              C. Disbetalipoproteinemia. Fenotipo III de Friedriksön.                                                                                       de Endocrinología y Nutrición; 2015. Capítulo 124. Epidemiología, diagnóstico y clasificación de las dislipemias;\n                                                                                                                                                            [citado 11 de noviembre de 2019]. Disponible en: https://manual.seen.es/article?id=55115050-34cc-451f-99b6-4b97ac18103c\n              D.  Hipertrigliceridemia familiar. Fenotipo IV de Friedriksön.\n\n\n\n              COMENTARIO\n              La hipertrigliceridemia          se caracteriza por niveles elevados de triglicéridos en ayunas y,\n              dado que existe una certidumbre menor respecto a la relación existente entre los triglicé-\n\n\n\n472                                                                                                                                                                                                                                                                                  473\n---\n                                                                                                                                                                                                                        OBESIDAD,                LÍPIDOS          8\n                                                                                                                                                                                            Y TRASTORNOS ELECTROLÍTICOS\n\n\n\n     43  ¿Qué exploración complementaria hubiera sido necesaria para completar la tríada                                                                mente a medida que aumentan los niveles de triglicéridos. Cualquier factor que aumente\n         típica del síndrome de hiperquilomicronemia, junto con la pancreatitis y la erupción                                                           la producción de VLDL puede agravar el riesgo de pancreatitis; el consumo de alcohol es el\n         cutánea?                                                                                                                                       factor que contribuye a ello más frecuentemente. Es necesario ingresar a los pacientes que\n                                                                                                                                                        estén sintomáticos y dar estrecho seguimiento a los triglicéridos séricos del paciente. Son\n         A. Fondo de ojo.                                                                                                                               imprescindibles la restricción del aporte calórico y del contenido de grasa de la dieta (se re-\n         B. Electromiograma.                                                                                                                            comienda un 10-15%) y la abstinencia de alcohol. Se debe iniciar un tratamiento con fibrato\n         C. TAC craneal.                                                                                                                                (fenofibrato) con ácidos grasos ω-3 (2-4 g/día) como tratamiento coadyuvante o ácido ni-\n         D.  Ecocardiograma.                                                                                                                            cotínico. En casos graves se puede considerar también la prescripción de lomitapida. Para\n                                                                                                                                                        los pacientes diabéticos, es preciso iniciar el tratamiento con insulina hasta conseguir un\n                                                                                                                                                        buen control glucémico. En general, se produce una fuerte disminución de los valores de\n         COMENTARIO                                                                                                                                     triglicéridos en los primeros 2-5 días. En un contexto agudo, la plasmaféresis puede reducir\n         La lipidemia retinalis es una de las manifestaciones clínicas de la hiperquilomicronemia.                                                      rápidamente la concentración de triglicéridos.\n         La presencia continuada de quilomicrones circulantes puede originar la aparición de nume-                                                      Referencias:\n                                                                                                                                                        • Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias. Rev Esp Cardiol. 2017; 70(2):115-64.\n         rosos xantomas cutáneos de pequeño tamaño, denominados xantomas eruptivos, y en el\n         fondo de ojo los vasos retinianos adquieren un aspecto rosado blanquecino característico\n         (lipidemia retinalis). En el páncreas, debido al enlentecimiento de la microcirculación y al                                               45  En cuanto al tratamiento estrictamente farmacológico (señale la respuesta cierta):\n         contacto prolongado de los quilomicrones con la lipasa pancreática, se generan cantidades\n         importantes      de ácidos grasos no esterificados con un potente efecto inflamatorio. Todo                                                    A. Los ácidos\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>SEMERGEN<|>ORGANIZATION<|>SEMERGEN is a medical organization that focuses on research and education in the field of family medicine and primary care.)\n##\n(\"entity\"<|>CARDONA F<|>PERSON<|>Cardona F is an author who contributed to the Manual de Endocrinología y Nutrición, providing insights into endocrinology and nutrition.)\n##\n(\"entity\"<|>ALCAIDE J<|>PERSON<|>Alcaide J is an author who contributed to the Manual de Endocrinología y Nutrición, focusing on the epidemiology and classification of dyslipidemias.)\n##\n(\"entity\"<|>FERNÁNDEZ GARCÍA JC<|>PERSON<|>Fernández García JC is an author who contributed to the Manual de Endocrinología y Nutrición, discussing various aspects of endocrinology.)\n##\n(\"entity\"<|>MADRID<|>GEO<|>Madrid is the capital city of Spain, where the Sociedad Española de Endocrinología y Nutrición is based.)\n##\n(\"entity\"<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>EVENT<|>The Manual de Endocrinología y Nutrición is a comprehensive guide on endocrinology and nutrition published by the Sociedad Española de Endocrinología y Nutrición.)\n##\n(\"relationship\"<|>CARDONA F<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Cardona F is one of the authors of the Manual de Endocrinología y Nutrición, contributing to its content<|>7)\n##\n(\"relationship\"<|>ALCAIDE J<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Alcaide J is one of the authors of the Manual de Endocrinología y Nutrición, contributing to its content<|>7)\n##\n(\"relationship\"<|>FERNÁNDEZ GARCÍA JC<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Fernández García JC is one of the authors of the Manual de Endocrinología y Nutrición, contributing to its content<|>7)\n##\n(\"relationship\"<|>SEMERGEN<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>SEMERGEN published the Manual de Endocrinología y Nutrición, which is a key resource in the field<|>8)\n##\n(\"relationship\"<|>SEMERGEN<|>MADRID<|>SEMERGEN is based in Madrid, the capital city of Spain<|>6)\n<|COMPLETE|>"}]}